5Ganda OP. Pathogenesis of macrovascular disease in the human diabetic. Diabetes, 1980, 29(11): 931-942.
6The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Corranittee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 1997, 20(7): 1 183- 1197.
7Celermajer DS, Sorensen KE, Gooch VM et al . Non invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet, 1992, 340(7): 1 111 - 1 115.
8Kimara Y, Matsumoto M, Miyauchi E et al . Noninvasive detection of endothelial dysfunction in elderly with NIDDM by ultrasonography. Echocardiography, 2001, 18(7) : 559 - 563.
9Pieper GM, langenstmer P, Siebeneich W. Diabetic - induced endothelial dysfunction in rat aorta: role of hydroxyl radical. Cardiovasc Res, 1997, 34(1): 145-156.
2[1] Elliott HL. Endothelial dysfunction in cardiovascular disease: Risk factor, risk marker, or surrogate end point[J]? J Cardiovasc Pharm, 1998, 32:S74-S77.
3[2] Celermajer DS, Sorensen KE, Bull C, et al. Endothelial-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction[J]. J Am Coll Cardiol,1994, 24: 1468-1474.
4[3] Tsao PS, Niebauer J, Buitrago R, et al. Interaction of diabetes and hypertension on determinants of endothelial adhesiveness[J]. Arterioscler Thromb Vasc Biol, 1998, 18: 947-953.
5[4] The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus[J]. Diabetes Care, 1997, 20: 1183-1197.
6[5] The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure[J]. Arch Intern Med, 1997, 157: 2413-2446.
7[6] Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis[J]. Lancet, 1992, 340: 1111-1115.
8[7] Ruderman NB, Haudenschild C. Diabetes as an atherogenic factor[J]. Prog Cardiovasc Dis, 1984, 26:373-412.
9[8] Stamler JS, Loh E, Roddy MA, et al. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans[J]. Circulation.1994, 89: 2035-2040.
10[9] Solzbach U, Hornig B, Jeserich M, et al. Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients[J]. Circulation, 1997,96: (5). 1513-1519.
6Celermajer DS,Sorensen KE,Gooch VM,et al.Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis.Lancet,1992,340(7):1111-1115.
7Sena CM,Nunes E,Louro T.Endothelial dysfunction in type 2 diabetes:effect of antioxidants.Rev Port Cardiol,2007,26(6):609-619.
8Ophir J,Cespedes I,Ponnekanti H,et al.Elastography:aqnantitative method for imaging the elasficity of biological tissues.Ultrason Imaging,1991,13(2):111-134.
9Jansson PA.Endothelial dysfunction in insulin resistance and type 2 diabetes.J Intern Med,2007,262(2):173-183.
10Ding H,Triggle CR.Endothelial cell dysfunction and the vascular complications associated with type 2 diabetes:assessing the health of the endothelium.Vasc Health Risk Manag,2005,1(1):55-71.
